AMGENAMGENAMGEN

AMGEN

No trades
See on Supercharts
Market capitalization
‪129.01 B‬CHF
‪5.66 B‬CHF
‪23.58 B‬CHF
‪534.59 M‬
Beta (1Y)
0.34

About AMGEN

CEO
Robert A. Bradway
Headquarters
Thousand Oaks
Website
Employees (FY)
‪26.7 K‬
Founded
1980
ISIN
US0311621009
FIGI
BBG002JV1GT8
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AMGN is 176.03 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange AMGEN stocks are traded under the ticker AMGN.
AMGEN is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
AMGN stock is 0% volatile and has beta coefficient of 0.34. Check out the list of the most volatile stocks — is AMGEN there?
One year price forecast for AMGEN has a max estimate of 346.41 CHF and a min estimate of 154.97 CHF.
AMGN earnings for the last quarter are 4.54 CHF per share, whereas the estimation was 4.27 CHF resulting in a 6.23% surprise. The estimated earnings for the next quarter are 3.87 CHF per share. See more details about AMGEN earnings.
AMGEN revenue for the last quarter amounts to ‪6.32 B‬ CHF despite the estimated figure of ‪6.34 B‬ CHF. In the next quarter revenue is expected to reach ‪6.84 B‬ CHF.
Yes, you can track AMGEN financials in yearly and quarterly reports right on TradingView.
AMGN net income for the last quarter is ‪645.76 M‬ CHF, while the quarter before that showed ‪1.58 B‬ CHF of net income which accounts for −59.23% change. Track more AMGEN financial stats to get the full picture.
Today AMGEN has the market capitalization of ‪128.53 B‬, it has decreased by 0.43% over the last week.
Yes, AMGN dividends are paid quarterly. The last dividend per share was 1.98 CHF. As of today, Dividend Yield (TTM)% is 3.29%. Tracking AMGEN dividends might help you take more informed decisions.
AMGEN dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMGEN stock right from TradingView charts — choose your broker and connect to your account.
AMGN reached its all-time high on Feb 4, 2019 with the price of 201.00 CHF, and its all-time low was 40.80 CHF and was reached on Mar 26, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪26.70 K‬ employees. See our rating of the largest employees — is AMGEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMGEN technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMGEN stock shows the neutral signal. See more of AMGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AMGEN future price: according to them, AMGN price has a max estimate of 346.41 CHF and a min estimate of 154.97 CHF. Read a more detailed AMGEN forecast: see what analysts think of AMGEN and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMGEN EBITDA is ‪10.35 B‬ CHF, and current EBITDA margin is 44.11%. See more stats in AMGEN financial statements.